Genex Pharmaceutical, Inc.
GENX · OTC
12/31/2007 | 9/30/2007 | 6/30/2007 | 3/31/2007 | |
|---|---|---|---|---|
| Revenue | $895 | $859 | $751 | $732 |
| % Growth | 4.1% | 14.4% | 2.6% | – |
| Cost of Goods Sold | $86 | $72 | $100 | $104 |
| Gross Profit | $809 | $787 | $651 | $627 |
| % Margin | 90.4% | 91.6% | 86.7% | 85.7% |
| R&D Expenses | $38 | $158 | $0 | $0 |
| G&A Expenses | $834 | $107 | $113 | $127 |
| SG&A Expenses | $851 | $548 | $450 | $364 |
| Sales & Mktg Exp. | $17 | $441 | $337 | $237 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $889 | $706 | $450 | $364 |
| Operating Income | -$80 | $81 | $201 | $264 |
| % Margin | -8.9% | 9.4% | 26.8% | 36% |
| Other Income/Exp. Net | $130 | $27 | $55 | $55 |
| Pre-Tax Income | $50 | $108 | $256 | $319 |
| Tax Expense | $123 | $50 | $98 | $120 |
| Net Income | -$73 | $59 | $158 | $199 |
| % Margin | -8.1% | 6.8% | 21% | 27.1% |
| EPS | -0.004 | 0.003 | 0.01 | 0.01 |
| % Growth | -224.2% | -67% | 0% | – |
| EPS Diluted | -0.004 | 0.003 | 0.01 | 0.01 |
| Weighted Avg Shares Out | 17,846 | 17,846 | 17,846 | 17,846 |
| Weighted Avg Shares Out Dil | 17,846 | 17,846 | 17,846 | 17,846 |
| Supplemental Information | – | – | – | – |
| Interest Income | $117 | $27 | $55 | $55 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $15 | $14 | $14 | $13 |
| EBITDA | $132 | $95 | $215 | $277 |
| % Margin | 14.7% | 11% | 28.6% | 37.8% |